We have demonstrated that minocycline not only suppressed the TNF-α-induced fusion of M13SV1-Cre human breast epithelial cells and MDA-MB-435-pFDR1 cancer cells, but also impaired the proliferation of both cell types in a dose-dependent manner [10, 11]. Here, TNF is linked to cancer.